These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 85849)

  • 1. Low-dose oral propranolol.
    Davies R; Pickering TG; Morganti A; Bianchetti G; Morselli PL; Romankiewicz J; Laragh JH
    Lancet; 1978 Apr; 1(8068):827-8. PubMed ID: 85849
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactive effect of ethanol administration on blood propranolol levels in rats.
    Moriya F; Ishizu H
    Arukoru Kenkyuto Yakubutsu Ison; 1991 Oct; 26(5):360-6. PubMed ID: 1772375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of propranolol. I. Elimination during oral absorption in man.
    Shand DG; Rangno RE
    Pharmacology; 1972; 7(3):159-68. PubMed ID: 5054586
    [No Abstract]   [Full Text] [Related]  

  • 4. Variable plasma propranolol levels in thyrotoxicosis.
    Rubenfeld S; Silverman VE; Welch KM; Mallette LE; Kohler PO
    N Engl J Med; 1979 Feb; 300(7):353-4. PubMed ID: 759897
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioavailability of propranolol in the dog.
    Tse FL; Sanders TM; Reo JP
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presystemic and systemic glucuronidation of propranolol.
    Walle T; Fagan TC; Conradi EC; Walle UK; Gaffney TE
    Clin Pharmacol Ther; 1979 Aug; 26(2):167-72. PubMed ID: 455886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.
    Wood AJ; Kornhauser DM; Wilkinson GR; Shand DG; Branch RA
    Clin Pharmacokinet; 1978; 3(6):478-87. PubMed ID: 719984
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.
    Evans GH; Shand DG
    Clin Pharmacol Ther; 1973; 14(4):487-93. PubMed ID: 4723255
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption kinetics of sublingually administered propranolol.
    Kates RE
    J Med; 1977; 8(6):393-402. PubMed ID: 272433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of propranolol.
    Routledge PA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):73-90. PubMed ID: 378502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.
    Evans GH; Shand DG
    Clin Pharmacol Ther; 1973; 14(4):494-500. PubMed ID: 4723256
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.
    Cleaveland CR; Shand DG
    Clin Pharmacol Ther; 1972; 13(2):181-5. PubMed ID: 4401564
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.
    George CF; Fenyvesi T; Conolly ME; Dollery CT
    Eur J Clin Pharmacol; 1972 Mar; 4(2):74-6. PubMed ID: 4655684
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood levels of long-acting propranolol in normal subjects and patients with renal failure.
    Kawasaki T; Ueno M; Uezono K; Abe I; Kawazoe N; Omae T; Nakamura S; Cooper RG; Stafford LE
    Fukuoka Igaku Zasshi; 1983 Nov; 74(11):737-43. PubMed ID: 6676140
    [No Abstract]   [Full Text] [Related]  

  • 16. Contribution of individual differences in gastric emptying to variability in plasma propranolol concentrations.
    Castleden CM; George CF; Short MD
    Br J Clin Pharmacol; 1978 Feb; 5(2):121-2. PubMed ID: 619945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple and rapid fluorometric method for the estimation of 1-(2-hydroxy-3-isopropylamino-propoxy)-naphthalene hydrochloride, propranolol, in blood.
    Ambler PK; Singh BN; Lever M
    Clin Chim Acta; 1974 Aug; 54(3):373-5. PubMed ID: 4411743
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of age on plasma levels of propranolol and practolol in man.
    Castleden CM; Kaye CM; Parsons RL
    Br J Clin Pharmacol; 1975 Aug; 2(4):303-6. PubMed ID: 1233989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol concentrations in plasma after insertion into the vagina.
    Patel LG; Warrington SJ; Pearson RM
    Br Med J (Clin Res Ed); 1983 Oct; 287(6401):1247-8. PubMed ID: 6416353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct measurement of propranolol bioavailability during accumulation to steady-state.
    Wood AJ; Carr K; Vestal RE; Belcher S; Wilkinson GR; Shand DG
    Br J Clin Pharmacol; 1978 Oct; 6(4):345-50. PubMed ID: 698031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.